Patents by Inventor Michèle Launay

Michèle Launay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic diarylmethylene derivatives, methods of preparing them and their uses in therapeutics
    Patent number: 6004994
    Abstract: The present invention relates to compounds of the formula: ##STR1## and their use in therapeutics, especially as medicaments with anti-inflammatory and analgesic properties.
    Type: Grant
    Filed: February 11, 1999
    Date of Patent: December 21, 1999
    Assignee: Laboratoires UPSA
    Inventors: Michele Launay, Eric Nicolai, Jean-Marie Teulon
  • Carbocyclic diarylmethylene derivatives, processes for their preparation and their uses in therapeutics
    Patent number: 5686460
    Abstract: The present invention relates to the carbocyclic diarylmethylene derivatives of formula (I): ##STR1## and to their use in therapeutics, especially as drugs with anti-inflammatory and analgesic properties.
    Type: Grant
    Filed: October 7, 1996
    Date of Patent: November 11, 1997
    Assignee: Laboratoires UPSA
    Inventors: Eric Nicolai, Michele Launay, Dominique Potin, Jean-Marie Teulon
  • Naphthyridine derivatives, their methods of preparation and pharmaceutical compositions in which they are present, useful especially as antiproliferative drugs
    Patent number: 5663181
    Abstract: The present invention relates to the derivatives of the formula ##STR1## and their addition salts, and to their use in therapeutics, especially as drugs having antiproliferative properties and affording an effective treatment for diseases such as cancer, psoriasis, atherosclerosis, restenosis phenomena or any other pathological condition due to cell proliferation.
    Type: Grant
    Filed: November 29, 1995
    Date of Patent: September 2, 1997
    Assignee: Laboratoires UPSA
    Inventors: Nicole Bru-Magniez, Michele Launay, Jean-Marie Teulon
  • Naphthyridine compounds which inhibit tyrosine kinase and their pharmaceutical compositions
    Patent number: 5364860
    Abstract: The present invention relates to the derivatives of the formula ##STR1## and their addition salts, and to their use in therapeutics, especially as drugs having antiproliferative properties and affording an effective treatment for diseases such as atherosclerosis, restenosis phenomena or any other pathological condition due to cell proliferation.
    Type: Grant
    Filed: July 27, 1993
    Date of Patent: November 15, 1994
    Assignee: Laboratoires UPSA
    Inventors: Nicole Bru-Magniez, Michele Launay, Jean-Marie Teulon
  • Thiazole derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present
    Patent number: 5192781
    Abstract: The present invention relates to the derivatives of formula (I): ##STR1## and their addition salts, and to their use in therapeutics, especially for the treatment of cardiovascular diseases and in particular for the treatment of hypertension and cardiac insufficiency.
    Type: Grant
    Filed: July 11, 1991
    Date of Patent: March 9, 1993
    Assignee: Laboratoires UPSA
    Inventors: Nicole Bru-Magniez, Michele Launay, Jean-Marie Teulon
  • Novel aminoalkylthio derivatives of triazolopyridine or triazoloquinoline, the processes for their preparation, and drugs, useful especially as analgesics, in which they are present
    Patent number: 4886805
    Abstract: The present invention relates to novel compounds corresponding to the formula: ##STR1## in which: n represents an integer between 1 and 8 and optimally 2 or 3; (CH.sub.2).sub.n --N can also form a ring or a heterocycle, for example having 5 to 7 atoms and preferably 6 atoms;R.sub.1 and R.sub.2 can represent hydrogen or a lower alkyl having 1 to 5 carbon atoms or can form, together with the nitrogen, a ring such as pyrrolidine, piperidine, morpholine, thiomorpholine, phenyltetrahydropyridine, piperazine or piperazine N-substituted by an alkyl, a phenyl or a heterocycle; in the case of the phenyltetrahydropyridines and the phenylpiperazines or heteroarylpiperazines, the phenyl or the heterocycle may or may not be substituted by halogens or methoxy, thiomethyl, hydroxyl, nitro, amino, cyano, lower alkyl, trifluoromethyl or trichloromethyl groups; andR.sub.3, R.sub.4 and R.sub.
    Type: Grant
    Filed: July 10, 1987
    Date of Patent: December 12, 1989
    Assignee: Centre D'Activite Et De Recherches Pharmaceutique Industrielle Biologique Medicale
    Inventors: Nicole Bru-Magniez, Jean-Marie Teulon, Michele Launay